As discussed above, the H3K27me3-demethylase KDM6A, a bivalent chromatin regulator, served as the underlying mechanism of dynamic and reversible nature of EMT and MET in breast cancer cells, indicating that KDM6A may be a potential target to block the onset of MET. The gene discussed is KDM6A; the disease is breast carcinoma.